- Home
- DBI vs GNFT Comparison
DBI vs GNFT Comparison
Compare DBI & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBI
- GNFT
- Stock Information
- Founded
- DBI 1991
- GNFT 1999
- Country
- DBI United States
- GNFT France
- Employees
- DBI N/A
- GNFT N/A
- Industry
- DBI Clothing/Shoe/Accessory Stores
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DBI Consumer Discretionary
- GNFT Health Care
- Exchange
- DBI Nasdaq
- GNFT Nasdaq
- Market Cap
- DBI 292.2M
- GNFT 190.6M
- IPO Year
- DBI 1991
- GNFT 2019
- Fundamental
- Price
- DBI $5.53
- GNFT $3.75
- Analyst Decision
- DBI Hold
- GNFT Strong Buy
- Analyst Count
- DBI 2
- GNFT 1
- Target Price
- DBI $5.75
- GNFT $13.00
- AVG Volume (30 Days)
- DBI 2.1M
- GNFT 8.9K
- Earning Date
- DBI 12-10-2024
- GNFT 09-19-2024
- Dividend Yield
- DBI 3.68%
- GNFT N/A
- EPS Growth
- DBI N/A
- GNFT N/A
- EPS
- DBI N/A
- GNFT 0.47
- Revenue
- DBI $3,050,038,000.00
- GNFT $86,225,222.00
- Revenue This Year
- DBI N/A
- GNFT $155.44
- Revenue Next Year
- DBI $2.23
- GNFT N/A
- P/E Ratio
- DBI N/A
- GNFT $7.55
- Revenue Growth
- DBI N/A
- GNFT 175.45
- 52 Week Low
- DBI $4.36
- GNFT $3.31
- 52 Week High
- DBI $11.57
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- DBI 46.98
- GNFT 29.68
- Support Level
- DBI $5.18
- GNFT $3.63
- Resistance Level
- DBI $6.21
- GNFT $3.94
- Average True Range (ATR)
- DBI 0.43
- GNFT 0.12
- MACD
- DBI -0.05
- GNFT 0.03
- Stochastic Oscillator
- DBI 42.47
- GNFT 0.69
About DBI Designer Brands Inc.
Designer Brands Inc is a designer, producer, and retailer of footwear and accessories. The company operates in three reportable segments: the U.S. Retail segment, the Canada Retail segment, and the Brand Portfolio segment. The U.S. Retail segment operates the DSW Designer Shoe Warehouse banner through its direct-to-consumer U.S. stores and e-commerce site. The Canada Retail segment operates The Shoe Company and DSW banners through its direct-to-consumer Canada stores and e-commerce sites. The Brand Portfolio segment earns revenue from the sale of wholesale products to retailers, commissions for serving retailers as the design and buying agent for products under private labels, and the sale of branded products through its direct-to-consumer e-commerce sites.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.